The WHO sets the dates for the review of Sinopharm and Sinovac COVID-19

The stand with the coronavirus vaccine candidate from Sinovac Biotech Ltd can be seen at the China International Trade in Services Fair (CIFTIS) in 2020, after the outbreak of COVID-19, in Beijing, China, on September 4, 2020. REUTERS / Tingshu Wang

World Health Organization (WHO) technical experts will review the COVID-19 vaccine from Chinese drugmaker Sinopharm on April 26 for a possible emergency list, followed by a sting of Sinovac (SVA.O) on May 3, the agency announced on Thursday.

“We would expect a decision a few days later,” the WHO said in response to a Reuters inquiry.

So far, COVID-19 vaccines from Pfizer (PFE.N) AstraZeneca (AZN.L) and Johnson & Johnson (JNJ.N) have received a WHO list – a confirmation of their safety and effectiveness that helps run regulatory agencies in countries. .

Our standards: Thomson Reuters’ principles of trust.